More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.26B
EPS
3.66
P/E ratio
20.1
Price to sales
4.04
Dividend yield
--
Beta
2.126797
Previous close
$92.21
Today's open
$91.73
Day's range
$91.32 - $95.60
52 week range
$60.11 - $156
show more
CEO
Waleed H. Hassanein
Employees
898
Headquarters
Andover, MA
Exchange
NASDAQ Global Market
Shares outstanding
34733883
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
PRNewsWire • Nov 12, 2026

TransMedics: 2027 Setting Up To Be A Pivotal Year
TransMedics Group is reiterated as a 'strong buy' due to compelling valuation and significant upside potential tied to multi-organ platform expansion. TMDX's 2027 catalysts include ENHANCE Heart, DENOVO Lung, CHOPS, OCS Kidney, and European expansion, all critical for achieving ambitious transplant volume targets. Q3 2026 saw record $203M revenue (+41% YoY), with management raising 2026 guidance to $764–$774M and operating margins expected at 12.5%–14%.
Seeking Alpha • Nov 11, 2026

TransMedics (TMDX) Just Reclaimed the 200-Day Moving Average
TransMedics (TMDX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TMDX broke through the 200-day moving average, which suggests a long-term bullish trend.
Zacks Investment Research • Nov 10, 2026

TransMedics: Growth Is Accelerating Again And 2027 Looks Promising
TransMedics Group Inc. demonstrates accelerating revenue growth, improved service margins, and market share gains in the recent quarter. TransMedics raised full-year revenue guidance to $764-774 million, with organic growth of 24-26% and service revenue up 60% YoY. Key 2027 growth catalysts include European expansion, new heart and lung programs, and the early-stage kidney opportunity.
Seeking Alpha • Nov 10, 2026

TransMedics: 3 Key Takeaways for Long-Term Investors
TransMedics raised 2026 revenue guidance to $764 million to $774 million. Third-quarter revenue reached $203 million, up 41% year over year.
The Motley Fool • Nov 10, 2026

TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
TransMedics (TMDX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, TMDX broke through the 20-day moving average, which suggests a short-term bullish trend.
Zacks Investment Research • Nov 9, 2026

TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average
From a technical perspective, TransMedics (TMDX) is looking like an interesting pick, as it just reached a key level of support. TMDX recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
Zacks Investment Research • Nov 9, 2026

TransMedics Group Q3 Earnings Call Highlights
TransMedics Group NASDAQ: TMDX raised its full-year revenue outlook after reporting record third-quarter revenue and transplant case volume, as gains in its liver and heart businesses helped offset a decline in U.S. deceased donor volume.
MarketBeat • Nov 6, 2026

Unusual Options Volume Report: 3 Stocks Moving After Earnings
Three stocks are seeing unusual options activity following their quarterly earnings reports: DraftKings Inc (NASDAQ:DKNG), TransMedics Group Inc (NASDAQ:TMDX), and Omada Health Inc (NASDAQ:OMDA).
Schaeffers Research • Nov 6, 2026

Moderna, JFrog, TransMedics, Ubiquiti And Other Big Stocks Moving Higher On Friday
U.S. stocks were mostly higher, with the Nasdaq Composite gaining around 400 points on Friday.
Benzinga • Nov 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell TransMedics Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.